93221 ⎘
Derivatives of urea, i.e. compounds containing any of the groups , the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
STAPHYLOCOCCUS AUREUS PBP4 INHIBITORS AND METHOD OF USE
#2COVALENT, CHEMOGENETIC ACTIVATORS FOR K2P POTASSIUM CHANNELS AND USES THEREOF
#34-SUBSTITUTED-PHENYL ACETAMIDES AND ARYLUREAS AS AGONISTS FOR THE ORPHAN RECEPTOR GPR88
#4COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#5COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#6COMPOSITIONS AND METHODS FOR TREATING CANCER
#7UREA DERIVATIVES AND THEIR USE AS CURATIVES AND CURATIVE ACCELERATORS FOR RESIN SYSTEMS
#8ENHANCED ERYTHROPOIESIS AND IRON METABOLISM
#9CATHEPSIN INHIBITORS
#10COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPase
#11SELECTIVE HISTONE DEACETYLASE 6 INHIBITORS
#12NAMPT MODULATORS
#13ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE
#14SUBSTITUTED UREA DIHYDROOROTATE DEHYDROGENASE INHIBITORS
#15Cathepsin inhibitors
#16Compositions and methods for the treatment of cancer
#17VASCULAR ADHESION PROTEIN-1 (VAP-1) MODULATORS AND THERAPEUTIC USES THEREOF
#18hTRPV1 chemical agents
#19Compositions and methods for treating cancer
#20Enhanced erythropoiesis and iron metabolism
#21Enhanced erythropoiesis and iron metabolism
#22Combined modalities for nucleosides and/or NADPH oxidase (NOX) inhibitors as myeloid-specific antiviral agents
#23Cathepsin inhibitors
#24Therapeutic compounds as inhibitors of the orexin-1 receptor
#25COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPASE
#26KCNQ2-5 CHANNEL ACTIVATOR
#27Vinylarene derivative and application
#28Fluorine atom-containing compound and use thereof
#29IDO inhibitors
#30KCNQ2-5 channel activator
#31HTRPVI chemical agents
#32Enhanced erythropoiesis and iron metabolism
#33Ureaurethanes for rheology control
#34Enhanced erythropoiesis and iron metabolism
#35Inhibitors of histone deacetylase
#36ANTI-PCSK9 COMPOUNDS AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR DISEASES
#37Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
#38Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
#39INHIBITORS OF HISTONE DEACETYLASE
#40Selective histone deactylase 6 inhibitors
#41KCNQ2-5 channel activator
#42Carbodiimides, method for the production and use thereof
#43Heat-sensitive recording material
#44Therapeutic compounds as inhibitors of the orexin-1 receptor
#45UREA AND BIS-UREA BASED COMPOUNDS AND ANALOGUES THEREOF USEFUL IN THE TREATMENT OF ANDROGEN RECEPTOR MEDIATED DISEASES OR DISORDERS
#46Enhanced erythropoiesis and iron metabolism
#47IDO inhibitors
#48Enhanced erythropoiesis and iron metabolism
#49CHALCONE-UREA DERIVATIVES AS INSULIN SENSORS
#50Use of DDX3X inhibitors for the treatment of pneumovirus infections
#51Tertiary amines for use in the treatment of cardiac disorders
#526-amino-5,6,7,8-tetrahydronaphthalen-2-yl or 3-aminochroman-7-yl derivatives
#53Bioinspired catalysis using oligourea helical foldamers
#54Inhibitors of histone deacetylase
#55N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
#56Substituted Urea eIF2alpha Kinase Activators
#57IDO inhibitors
#58Inhibitors of histone deacetylase
#59Compounds useful as immunomodulators
#60Selective histone deactylase 6 inhibitors
#61Compound, dispersant and toner
#62Carbodiimides having terminal urea and/or urethane groups, methods for producing said carbodiimides, and use of said carbodiimides
#63Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases
#64SMALL MOLECULES FOR RESTORING FUNCTION TO P53 CANCER MUTANTS
#65Enhanced erythropoiesis and iron metabolism
#66Compounds and methods for treating mammalian gastrointestinal microbial infections
#67Agonists of Src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same
#68Tertiary amines for use in the treatment of cardiac disorders
#69Compositions and methods for the treatment of respiratory disorders
#70N-substituted carbamic acid ester production method and isocyanate production method using the N-substituted carbamic acid ester
#71Polymeric Compounds And Methods Of Making And Using The Same
#72Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#73Kinase inhibitors
#74Compounds for treating ophthalmic diseases and disorders
#75Agonists of Src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same
#76N-substituted carbamic acid ester production method, isocyanate production method using such N-substituted carbamic acid ester, and composition for transfer and storage of N-substituted carbamic acid ester comprising N-substituted carbamic acid ester and aromatic hydroxy compound
#77N-substituted carbamic acid ester production method, isocyanate production method using such N-substituted carbamic acid ester, and composition for transfer and storage of N-substituted carbamic acid ester comprising N-substituted carbamic acid ester and aromatic hydroxy compound
#78Enhanced Erythropoiesis and Iron Metabolism
#79Inhibitors of histone deacetylase
#80Inhibitors of histone deacetylase
#81Cationic bis-urea compounds as effective antimicrobial agents
#82Substituted N-(2-arylamino)aryl sulfonamide-containing combinations
#83Phenyl N-mustard linked to DNA-affinic molecules or water-soluble aryl rings, method and their use as cancer therapeutic agents
#84Histone deacetylase inhibitors and methods of use thereof
#85COMPOUNDS AND THERAPEUTIC USES THEREOF
#86Electrophotographic photosensitive member, process cartridge, electrophotographic apparatus, method of producing electrophotographic photosensitive member, and urea compound
#87CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#889-substituted minocycline compounds
#89Compounds, pharmaceutical compositions and uses thereof
#902,3-dihydro-1-indene-2-yl urea derivative and pharmaceutical application of same
#91Glycine compound
#92Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
#93N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
#94OMEGA CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
#95Phenethanolamine derivatives for treatment of respiratory diseases
#96Method for producing rheologically effective urea urethanes in organic salts
#97Dendron, polyurethane with side-chain regular dendron, and producing methods thereof
#98Tetrahydro-naphthalene derivatives
#99N-substituted carbamic acid ester production method and isocyanate production method using the N-substituted carbamic acid ester
#100N-substituted carbamic acid ester production method, isocyanate production method using such N-substituted carbamic acid ester, and composition for transfer and storage of N-substituted carbamic acid ester comprising N-substituted carbamic acid ester and aromatic hydroxy compound
#101Thermal responsive molecule
#102Histone deacetylase inhibitors and methods of use thereof
#103Enhanced erythropoiesis and iron metabolism
#104Enhanced erythropoiesis and iron metabolism
#105DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL) PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR
#106Phenethanolamine derivatives for treatment of respiratory diseases
#107ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF
#108Enhanced erythropoiesis and iron metabolism
#109Enhanced erythropoiesis and iron metabolism
#110Cell differentiation inducer
#111Compounds, compositions, and methods for the treatment of synucleinopathies
#112Compounds for treating ophthalmic diseases and disorders
#113Certain Chemical Entities, Compositions, and Methods
#1149-substituted minocycline compounds
#115Imidazopyridinyl benzamide mitotic kinesin inhibitors
#116Imidazopyridinyl benzamide mitotic kinesin inhibitors
#117N- (2-aminophenyl) benzamide derivative having urea structure
#118CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#1195-HT2C Receptor Agonists as Anorectic Agents
#120Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses
#121Inhibitors of Histone Deacetylase
#122Compounds, Compositions and Methods
#123Novel triphenylmethane derivative, organic gellant containing the same, organic gel, and organic fiber
#124Histone deacetylase inhibitors and methods of use thereof
#125Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases
#126Inhibitors of IMPDH enzyme
#127Modulators of Chemokine Receptor Activity
#128Tetrahydro-naphthalene derivatives
#129Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
#130Chemokine receptor modulators
#131Certain chemical entities, compositions, and methods
#132ANTIVIRAL INHIBITION OF CAPSID PROTEINS
#133C5a receptor antagonists
#134Cell differentiation inducer
#135Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
#136Amide-containing polymers for rheology control
#137Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
#138Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors
#139Phenethanolamine derivatives for treatment of respiratory diseases
#140Compounds, compositions and methods for the treatment of synucleinopathies
#141Novel Biphenyl Compounds And Their Use
#142Urea derivatives as integrin a4 antagonists
#143Amide inhibitors of leukotriene A4 hydrolase
#144Imidazoyl-benzamide anti-cancer agents
#145Novel urea derivatives and their medical use
#146Calcium receptor modulating agents
#147Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
#148Amide-containing polymers for rheology control
#149Compound having activity for inhibiting dioxin toxicity, pharmaceutical composition comprising the compound and method for treating disease resulting from dioxin toxicity using the compound
#150Method for inhibiting the replication of herpes viruses
#151Antibacterial agents
#152Hydroxy tetrahydro-naphthalenylurea derivatives
#153N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
#154Compounds, compositions, and methods
#155Aminobenzophenone compounds
#156Tetrahydro-naphthalene derivatives
#157Imidazopyridinyl-benzamide anti-cancer agents
#158Cell adhesion inhibitors
#159Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
#160Positive allosteric modulators of the nicotinic acetylcholine receptor
#161Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl) ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester
#162Lidocaine analogs and methods of making and using same
#1632,3-Oxidosqualene-lanosterol cyclase inhibitors
#164Compounds, compositions and methods
#165Urea derivatives
#166Inhibitors of IMPDH enzyme
#167Calcium receptor modulating agents
#168Phenethanolamine derivatives for treatment of respiratory diseases
#169Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
#170Histone deacetylase inhibitors and methods of use thereof
#171Enhanced erythropoiesis and iron metabolism
#172Histone deacetylase inhibitors and methods of use thereof